Daxor SG&A Expenses 2010-2011 | DXR

Daxor sg&a expenses from 2010 to 2011. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
Daxor Annual SG&A Expenses
(Millions of US $)
2011 $4
2010 $3
2009 $3
Daxor Quarterly SG&A Expenses
(Millions of US $)
2011-12-31 $0
2011-09-30 $1
2011-06-30 $1
2011-03-31 $2
2010-12-31 $1
2010-09-30 $1
2010-06-30 $1
2010-03-31 $1
2009-12-31 $1
2009-09-30 $1
2009-06-30 $1
2009-03-31 $1
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $0.041B $0.000B
Daxor Corporation is a medical device manufacturing corporation with additional biotech services.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $17.770B 10.75
Quest Diagnostics (DGX) United States $15.772B 16.30
DaVita (DVA) United States $12.902B 16.03
Elanco Animal Health (ELAN) United States $8.737B 22.67
Encompass Health (EHC) United States $8.698B 22.26
Chemed (CHE) United States $8.393B 26.01
Option Care Health (OPCH) United States $5.183B 19.62
RadNet (RDNT) United States $4.332B 90.21
Amedisys (AMED) United States $2.979B 21.10
Astrana Health (ASTH) United States $2.321B 31.39
LifeStance Health (LFST) United States $2.129B 0.00
Addus HomeCare (ADUS) United States $1.879B 26.89
U.S Physical Therapy (USPH) United States $1.546B 41.36
Pennant (PNTG) United States $0.707B 37.37
Aveanna Healthcare Holdings (AVAH) United States $0.502B 0.00
Atai Life Sciences (ATAI) Germany $0.263B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.025B 0.00
ATI Physical Therapy (ATIP) United States $0.021B 0.00
Novo Integrated Sciences (NVOS) United States $0.020B 0.00
Psychemedics (PMD) United States $0.014B 0.00
Ontrak (OTRK) United States $0.012B 0.00
IMAC Holdings (BACK) United States $0.003B 0.00